Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Phase of Trial: Phase III
Latest Information Update: 22 Apr 2017
At a glance
- Drugs Darapladib (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms AIM-III
- 07 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record. (NCT01067339)
- 22 Sep 2015 Planned End Date changed from 1 Apr 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.
- 22 Sep 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.